A Deep Dive into Blood Glucose Monitoring Systems Market 2025: Key Drivers, Growth Factors, and Projections 2025-2034

What Are the Market Size and Growth Forecast for the Blood Glucose Monitoring Systems Market?
The market for blood glucose monitoring systems has seen significant growth over the recent years. There will be a leap in its size from $16.48 billion in 2024 to $17.8 billion in 2025, expanding at a compound annual growth rate (CAGR) of 8.0%. The strong growth observed during the historical period can be linked to the global rise in diabetes cases, heightened awareness that has led to more adoption of these monitoring systems, favorable policies for managing diabetes, improved access to healthcare services, and enhanced precision of glucose meters.

The market for blood glucose monitoring systems is predicted to experience solid expansion in the coming years, reaching a valuation of $23.99 billion in 2029 with a compound annual growth rate (CAGR) of 7.7%. This anticipated growth in the forecast period is due to factors such as the rise in custom treatment plans utilizing glucose data, increased incidence of diabetes, an aging population, a heightened uptake in emerging regions, improved connectivity, and data management. Key trends throughout the forecast period are expected to include integration with wearable technology and smart devices, advancements in sensor technology, personalized healthcare, telemedicine, remote patient monitoring, and superior connectivity and data administration.

What Are the Primary Growth Drivers for the Blood Glucose Monitoring Systems Market?
The growth of the blood glucose monitoring systems market is anticipated to escalate due to the increasing occurrence of diabetes within the population. This rise is heavily influenced by various factors like chronically inactive lifestyles, unhealthy eating habits, the process of aging, and hereditary disposition. The purpose of blood glucose monitoring systems lies in watching over and controlling the levels of blood sugar to aid in handling the disease and dodge any other complications. As an example, the Australian Bureau of Statistics, a government institution based in Australia, revealed that in 2022, around 5.3% of the Australian population, equivalent to 1.3 million individuals, were identified as having diabetes. The gender gap was minimal, with males possessing a rate of 5.8% and females 4.9%. The prevalence of diabetes has been consistently growing and tends to surge significantly as individuals age, peaking at 18.7% for those more than 75 years old. Most prevalent is type 2 diabetes, contributing to 87.6% of all cases. Other influential factors include being born abroad, residing in disadvantaged regions, and having a disability, all associated with escalated diabetes rates. Consequently, the spike in the diabetic population will be a key driver for the blood glucose monitoring systems market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17097&type=smp

Which Key Market Leaders Are Driving Blood Glucose Monitoring Systems Industry Growth?
Major companies operating in the blood glucose monitoring systems market are F. Hoffmann-La Roche Ltd., Sanofi S.A., Medtronic plc, Novo Nordisk A/S, B. Braun Melsungen AG, Terumo India Private Limited, Dexcom Inc., SD Biosensor Co. Ltd., Arkray Inc., Abbott India Limited, Ypsomed Holding AG, LifeScan IP Holdings LLC, Ascensia Diabetes Care Holdings AG, TaiDoc Technology Corporation, Nemaura Medical Inc., Bionime GmbH, Acon Laboratories Inc., Nipro India Corporation Private Limited., Rossmax International Ltd, AgaMatrix Inc., A. Menarini Diagnostics S.r.l., Medisana GmbH, Intuity Medical Inc.

What Are the Emerging Trends in the Blood Glucose Monitoring Systems Industry?
A variety of substantial companies in the glucose monitoring systems sector are dedicated to the creation of innovative, cutting-edge glucose monitoring technologies. This includes solutions such as sophisticated hybrid closed-loop systems and mobile apps enabling immediate data access and administration. These hybrid closed-loop systems provide automatic insulin delivery based on current glucose levels, enhancing blood sugar management for diabetes patients. For example, DexCom Inc., a continuous glucose monitoring systems manufacturer headquartered in the US, rolled out Dexcom ONE+ in multiple European countries in February 2024. The premium sensor technology and features of Dexcom ONE+ make it a user-friendly and extremely efficient continuous glucose monitoring (CGM) option for insulin-using people with type 1 or type 2 diabetes. The system comprises a water-resistant sensor, a transmitter relay CGM readings, and a Dexcom One app compatible with smartphones. Dexcom ONE+ grants real-time blood glucose observation to the user and up to ten other individuals, facilitating collective monitoring.

What Are the Main Segments in the Blood Glucose Monitoring Systems Market?
The blood glucose monitoring systems market covered in this report is segmented -

1) By Type: Non-Invasive, Invasive
2) By Device Type: Continuous Glucose Monitoring Systems, Self-Monitoring Blood Glucose Systems
3) By Testing Site: Fingertip Testing, Alternate Site Testing
4) By Distribution Channel: Institutional Sales, Retail Sales
5) By Application: Type 2 Diabetes, Type 1 Diabetes, Gestational Diabetes

Subsegments:
1) By Non-Invasive: Optical Sensors, Ultrasound-Based Sensors, Bioimpedance-Based Sensors, Electromagnetic Sensors, Tear Or Saliva-Based Sensors
2) By Invasive: Continuous Glucose Monitoring (CGM) Systems, Self-Monitoring Blood Glucose (SMBG) Systems, Implantable Glucose Monitoring Devices, Flash Glucose Monitoring Systems

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/blood-glucose-monitoring-systems-global-market-report

Which Geographic Area Leads the Blood Glucose Monitoring Systems Market?
North America was the largest region in the blood glucose monitoring systems market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the blood glucose monitoring systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Blood Glucose Monitoring Systems Global Market Report?

- Market Size Analysis: Analyze the Blood Glucose Monitoring Systems Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Blood Glucose Monitoring Systems Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Blood Glucose Monitoring Systems Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Blood Glucose Monitoring Systems Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17097

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.